Urethritis-API Insights, 2017

Publisher Name :
Date: 01-Jan-2017
No. of pages: 60
Delivery of the Report will take 2-3 working days once order is placed.

The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market.

India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positioned them in a very strategic space in the global pharmaceutical supply chain, with a vast majority of the APIs and intermediates being sourced from markets such as India and China.

DelveInsight's, Urethritis -API Insights, 2017 Report describes the current therapeutics that is propelling the pharmaceutical markets worldwide. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries related to the Urethritis. It also provides the India and China API Manufactures who are driving the current API Market. The report also highlights the patent and patent exclusivity information. The research analysis also presents the global sales data till 2016.

Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts. Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • A snapshot of the global Market therapeutics scenario for Urethritis.

  • A review of the marketed products under prescription for Urethritis, regulatory information and marketing status.

  • Coverage of global patent coverage and detailed commentaries on the US patent challenges.

  • Graphical representation of investigational products for patent expiry and market exclusivities across the globe.

  • Product profiles for marketed products for Urethritis with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.

  • Coverage of API Manufacturers for Urethritis drugs in the United States, Europe and Asian Regions with location details.

  • Coverage of Regulatory filings in the US, Europe, and Asia specifically India and China for Urethritis drugs.

  • Key discontinued Marketed products.

  • Global Sales Figure from 2012-2016.Reasons to Buy

  • Evaluate the marketing status and exclusivity details of Urethritis key products to exploit opportunities for generic drug development opportunities.

  • Key players in the pharmaceutical industry.

  • Strategic drivers and restraints of this market are revealed and market opportunities and challenges are identified.

  • Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Urethritis.

  • API intelligence over marketed drugs for Urethritis and gaining primary intelligence over active ingredients manufacturers across the globe.

  • Uncovering opportunities in the rapidly growing the US markets.

Urethritis-API Insights, 2017

Table of Contents

Indication Overview
Marketed Drugs Assessment
Marketed Details of Drugs by Application Type
Marketed Details of Drugs (NDA) by Marketing Status
Marketed Details of Drugs by Patent Expiration Timeline
The Active Pharmaceutical Ingredient (API) Manufacturers Assessment
The API Manufacturers by the United States Drug Master File (US DMF) Status
The API Manufacturers by the US DMF Status (Drug Specific)
Drugs Market Data and Sales Figures (2012-2016)
Marketed Drugs Information
Drugs Description
Global Active Pharmaceutical Manufacturers
Approval Status
Patent and Exclusivity Details
Company Overview
Discontinued Drugs Information

List of Tables

Urethritis Therapeutic Market, US, Marketed Drugs by Application Type, 2017
Urethritis Therapeutic Market, US, Marketed Drugs by Marketing Status, 2017
Urethritis Therapeutic Market, US, (Year), 2017
Urethritis Marketed Drugs, API Manufacturers by US DMF Status, 2017
Urethritis Marketed Drugs, US DMF Status Drug Specific (Number), 2017
Urethritis Therapeutic Market, Global Sales (in million USD), 2017
Urethritis Marketed Drugs, API Manufacturers, Global, 2017
Discontinued Drugs for Urethritis, 2017

List of Figures

Urethritis Therapeutic Market, US, Marketed Drugs by Application Type (%), 2017
Urethritis Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2017
Urethritis Therapeutic Market, US, (Year), 2017
Urethritis Marketed Drugs, API Manufacturers by US DMF Status (%), 2017
Urethritis Marketed Drugs, US DMF Status Drug Specific (Number), 2017
Urethritis Therapeutic Market, Global Sales (in million USD), 2017
Urethritis Marketed Drugs, Patent/Exclusivity Expiry (Year), 2017
  • Nocturia - Pipeline Review, H1 2017
    Published: 28-Feb-2017        Price: US 2000 Onwards        Pages: 33
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nocturia - Pipeline Review, H1 2017, provides an overview of the Nocturia (Genito Urinary System And Sex Hormones) pipeline landscape.Nocturia is defined as need to urinate at least twice during the night. This condition becomes more common as people age and occurs in both men and women, sometimes for different reasons. Causes of nocturia include congestive heart failure, edema of lower extremities, sleeping d......
  • Urinary Incontinence - Pipeline Review, H1 2017
    Published: 28-Feb-2017        Price: US 2000 Onwards        Pages: 66
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Urinary Incontinence - Pipeline Review, H1 2017, provides an overview of the Urinary Incontinence (Genito Urinary System And Sex Hormones) pipeline landscape.Urinary incontinence is a loss of control of the bladder. In some cases, it may result in a total loss of the bladder's contents or it may just cause minor leakage. Symptoms include stress incontinence, rashes and other skin disorders. Risk factors includ......
  • Interstitial Cystitis (Painful Bladder Syndrome)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
    Published: 01-Jan-2017        Price: US 2000 Onwards        Pages: 100
    DelveInsight's Report, "Interstitial Cystitis (Painful Bladder Syndrome)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Interstitial Cystitis (Painful Bladder Syndrome) Report is to understand the market and pipeline status of the drugs around the Interstitial Cystitis (Painful Bladder Syndrome) to explore th......
  • Interstitial Cystitis  - Epidemiology Forecast To 2023
    Published: 01-Jan-2017        Price: US 2750 Onwards        Pages: 60
    DelveInsight "Interstitial Cystitis - Epidemiology Forecast To 2023" provides an overview of the epidemiology trends of Interstitial Cystitis in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Interstitial Cystitis prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need ass......
  • Bladder Pain-Pipeline Insights, 2017
    Published: 01-Jan-2017        Price: US 1250 Onwards        Pages: 60
    DelveInsight's, " Bladder Pain-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Bladder Pain. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fun......
  • Interstitial Cystitis-Pipeline Insights, 2017
    Published: 01-Jan-2017        Price: US 1250 Onwards        Pages: 60
    DelveInsight's, " Interstitial Cystitis-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Interstitial Cystitis. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations,......
  • Interstitial Cystitis (Painful Bladder Syndrome)-Pipeline Insights, 2017
    Published: 01-Jan-2017        Price: US 1250 Onwards        Pages: 60
    DelveInsight's, " Interstitial Cystitis (Painful Bladder Syndrome)-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Interstitial Cystitis (Painful Bladder Syndrome). The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activ......
  • Urinary Incontinence-API Insights, 2017
    Published: 01-Jan-2017        Price: US 1250 Onwards        Pages: 60
    The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have......
  • Nocturnal Enuresis - Epidemiology Forecast To 2023
    Published: 01-Jan-2017        Price: US 2750 Onwards        Pages: 60
    DelveInsight "Nocturnal Enuresis - Epidemiology Forecast To 2023" provides an overview of the epidemiology trends of Nocturnal Enuresis in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Nocturnal Enuresis prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs